Genprex, Inc. Gains 29.05%
Fri, May 31, 2024 at 07:20 PM
Genprex, Inc. (GNPX:NASDAQ) rocketted at $3.11, representing a gain of 29%. On Fri, May 31, 2024, GNPX:NASDAQ touched a New 2-Week High of $3.11. The stock appeared on our News Catalysts scanner on Thu, May 30, 2024 at 09:49 AM in the 'MISCELLANEOUS' category. From Fri, May 17, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Fri, May 31, 2024 at $4.09 with a volume of 3M+.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- Ault Disruptive Technologies Corporation (ADRT:NYSEMKT), 233.33%
- Brand Engagement Network Inc Com (BNAI:NASDAQ), 110.85%
- Portage Biotech Inc. (PRTG:NASDAQ), 91.56%
- SRAX, Inc. (SRAX:NASDAQ), 80%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 39.51%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 31.5%
- Selina Hospitality PLC (SLNA:NASDAQ), 31.15%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 30.69%
- Vaccinex, Inc. (VCNX:NASDAQ), 30.13%
- Genprex, Inc. (GNPX:NASDAQ), 29.05%